Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis
- PMID: 4053393
- DOI: 10.1016/0009-8981(85)90182-2
Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis
Abstract
Patients suffering from cerebrotendinous xanthomatosis, an inborn error of metabolism in bile acid synthesis, were given oral treatment with chenodeoxycholic acid, ursodeoxycholic acid, cholic acid and taurocholic acid. The effectiveness of the different therapies was evaluated by measuring the urinary excretion of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol, which should decrease, when the administered bile acid is able to suppress endogenous bile acid synthesis. From the results it is concluded that chenodeoxycholic acid and cholic acid activate the bile acid negative feedback mechanism, contrary to ursodeoxycholic acid and taurine conjugated cholic acid. Either cholic acid or chenodeoxycholic acid are the therapies of choice for the treatment of cerebrotendinous xanthomatosis. For various reasons the use of cholic acid is especially recommended.
Similar articles
-
Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26.J Clin Invest. 1985 Aug;76(2):744-51. doi: 10.1172/JCI112030. J Clin Invest. 1985. PMID: 4031069 Free PMC article.
-
Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography.J Lipid Res. 1985 Jun;26(6):690-8. J Lipid Res. 1985. PMID: 4031647
-
A case of cerebrotendinous xanthomatosis: effects of ursodeoxycholic acid administration on serum bile acids and cholestanol.Jpn J Med. 1982 Jul;21(3):210-5. doi: 10.2169/internalmedicine1962.21.210. Jpn J Med. 1982. PMID: 7143816
-
[Delta 4-3-oxosteroid 5 beta-reductase deficiency].Ryoikibetsu Shokogun Shirizu. 1998;(19 Pt 2):282-4. Ryoikibetsu Shokogun Shirizu. 1998. PMID: 9645062 Review. Japanese. No abstract available.
-
The medical treatment of gallstones.Annu Rev Med. 1980;31:59-77. doi: 10.1146/annurev.me.31.020180.000423. Annu Rev Med. 1980. PMID: 6994627 Review. No abstract available.
Cited by
-
Prospective treatment of cerebrotendinous xanthomatosis with cholic acid therapy.J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S241-5. doi: 10.1007/s10545-008-0815-z. Epub 2008 Dec 27. J Inherit Metab Dis. 2008. PMID: 19125350
-
Development of Photodynamic Antimicrobial Chemotherapy (PACT) for Clostridium difficile.PLoS One. 2015 Aug 27;10(8):e0135039. doi: 10.1371/journal.pone.0135039. eCollection 2015. PLoS One. 2015. PMID: 26313448 Free PMC article.
-
Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.J Inherit Metab Dis. 1988;11(1):56-75. doi: 10.1007/BF01800057. J Inherit Metab Dis. 1988. PMID: 3128689
-
Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.Orphanet J Rare Dis. 2014 Nov 26;9:179. doi: 10.1186/s13023-014-0179-4. Orphanet J Rare Dis. 2014. PMID: 25424010 Free PMC article. Review.
-
Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX).J Inherit Metab Dis. 2017 Nov;40(6):771-781. doi: 10.1007/s10545-017-0093-8. Epub 2017 Oct 4. J Inherit Metab Dis. 2017. PMID: 28980151 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
